Therapeutic Plasma Exchange in MG

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Myasthenia Gravis
Interventions
OTHER

Skin biopsy

An optional skin biopsy will be performed in up to 5 subjects at baseline and 2 weeks after therapeutic plasma exchange is completed.

OTHER

Single Fiber Electromyography

An optional SFEMG study will be performed at baseline and 2 weeks after therapeutic plasma exchange is completed.

Trial Locations (2)

27710

Duke University Hospital, Durham

Unknown

UNC Chapel Hill, Chapel Hill

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

Duke University

OTHER

NCT01927692 - Therapeutic Plasma Exchange in MG | Biotech Hunter | Biotech Hunter